Forte Biosciences, Inc. (FBRX)
NASDAQ: FBRX · Real-Time Price · USD
7.43
-0.33 (-4.25%)
At close: Apr 1, 2025, 4:00 PM
7.90
+0.47 (6.38%)
After-hours: Apr 1, 2025, 4:12 PM EDT
Forte Biosciences Stock Forecast
FBRX's stock price has decreased by -58% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Forte Biosciences stock have an average target of 77.58, with a low estimate of 64 and a high estimate of 100. The average target predicts an increase of 944.15% from the current stock price of 7.43.
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 4, 2024.
Analyst Ratings
The average analyst rating for Forte Biosciences stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Jan 21, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $64 | Strong Buy | Maintains | $64 | +761.37% | Dec 4, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $3 → $64 | Strong Buy | Maintains | $3 → $64 | +761.37% | Nov 15, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $75 | Strong Buy | Maintains | $75 | +909.42% | Aug 19, 2024 |
| Brookline Capital | Brookline Capital | Strong Buy Initiates $100 | Strong Buy | Initiates | $100 | +1,245.90% | May 30, 2024 |
Financial Forecast
Revenue This Year
n/a
from 67.50M
Revenue Next Year
n/a
EPS This Year
-3.58
from -12.17
EPS Next Year
-2.82
from -3.58
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | ||
| Avg | n/a | n/a | n/a | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -3.61 | -2.28 | -1.74 | ||
| Avg | -3.58 | -2.82 | -1.69 | ||
| Low | -3.51 | -3.29 | -1.63 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.